NASDAQ:THTX

Theratechnologies News Headlines

$3.65
-0.18 (-4.70 %)
(As of 04/14/2021 05:20 PM ET)
Add
Compare
Today's Range
$3.52
Now: $3.65
$3.81
50-Day Range
$2.92
MA: $3.43
$3.96
52-Week Range
$1.68
Now: $3.65
$4.25
Volume394,337 shs
Average Volume611,715 shs
Market Capitalization$342.52 million
P/E RatioN/A
Dividend YieldN/A
Beta1.79

Headlines

Theratechnologies (NASDAQ THTX) News Headlines Today

SourceHeadline
Theratechnologies Reports First Quarter 2021 Financial Results and Recent Business HighlightsTheratechnologies Reports First Quarter 2021 Financial Results and Recent Business Highlights
finance.yahoo.com - April 14 at 9:25 AM
Theratechnologies (THTX) Scheduled to Post Earnings on WednesdayTheratechnologies (THTX) Scheduled to Post Earnings on Wednesday
americanbankingnews.com - April 13 at 9:12 AM
Morning News Call - Canada, April 13 - Yahoo FinanceMorning News Call - Canada, April 13 - Yahoo Finance
finance.yahoo.com - April 13 at 8:17 AM
Theratechnologies to Present at the Bloom Burton & Co. Healthcare Investor Conference - Yahoo FinanceTheratechnologies to Present at the Bloom Burton & Co. Healthcare Investor Conference - Yahoo Finance
finance.yahoo.com - April 13 at 12:22 AM
Theratechnologies to Present at the Bloom Burton & Co. Healthcare Investor Conference - GlobeNewswireTheratechnologies to Present at the Bloom Burton & Co. Healthcare Investor Conference - GlobeNewswire
globenewswire.com - April 12 at 7:07 PM
Theratechnologies to Announce Financial Results for Its First Quarter Fiscal 2021 - GlobeNewswireTheratechnologies to Announce Financial Results for Its First Quarter Fiscal 2021 - GlobeNewswire
globenewswire.com - April 12 at 2:07 PM
Theratechnologies to Announce Financial Results for Its First Quarter Fiscal 2021Theratechnologies to Announce Financial Results for Its First Quarter Fiscal 2021
finance.yahoo.com - April 12 at 2:07 PM
Health Care Stocks Are Up an Insane 37.9% in 2021 - The Motley Fool CanadaHealth Care Stocks Are Up an Insane 37.9% in 2021 - The Motley Fool Canada
fool.ca - April 9 at 8:46 AM
Theratechnologies Inc. (NASDAQ:THTX) Sees Large Decrease in Short InterestTheratechnologies Inc. (NASDAQ:THTX) Sees Large Decrease in Short Interest
americanbankingnews.com - March 30 at 10:02 AM
Theratechnologies Announces Two Strategic Hires to Support its Commercial and Pipeline Assets - Yahoo FinanceTheratechnologies Announces Two Strategic Hires to Support its Commercial and Pipeline Assets - Yahoo Finance
finance.yahoo.com - March 29 at 1:22 PM
Theratechnologies Announces First Patient Dosed in Phase 1 Clinical Trial of TH1902 for Sortilin Positive Solid Tumors - GlobeNewswireTheratechnologies Announces First Patient Dosed in Phase 1 Clinical Trial of TH1902 for Sortilin Positive Solid Tumors - GlobeNewswire
globenewswire.com - March 24 at 8:57 AM
Theratechnologies Announces First Patient Dosed in Phase 1 Clinical Trial of TH1902 for Sortilin Positive Solid TumorsTheratechnologies Announces First Patient Dosed in Phase 1 Clinical Trial of TH1902 for Sortilin Positive Solid Tumors
finance.yahoo.com - March 24 at 8:57 AM
Theratechnologies Inc. (NASDAQ:THTX) Receives Average Recommendation of "Hold" from BrokeragesTheratechnologies Inc. (NASDAQ:THTX) Receives Average Recommendation of "Hold" from Brokerages
americanbankingnews.com - March 24 at 5:16 AM
Streaming Services Grow on Coronavirus Crisis: 4 Stocks to Watch - NasdaqStreaming Services Grow on Coronavirus Crisis: 4 Stocks to Watch - Nasdaq
nasdaq.com - March 23 at 5:55 PM
Theratechnologies (THTX) Enters Overbought Territory - Yahoo FinanceTheratechnologies (THTX) Enters Overbought Territory - Yahoo Finance
finance.yahoo.com - March 23 at 5:55 PM
Theratechnologies (THTX) Enters Overbought TerritoryTheratechnologies (THTX) Enters Overbought Territory
finance.yahoo.com - March 23 at 7:54 AM
27 Stocks Moving in Fridays Pre-Market Session - Benzinga27 Stocks Moving in Friday's Pre-Market Session - Benzinga
benzinga.com - March 19 at 8:18 AM
Theratechnologies Announces Two E-Posters on TH1902 To Be Presented at American Association for Cancer Research (AACR) Annual Meeting 2021 - Yahoo FinanceTheratechnologies Announces Two E-Posters on TH1902 To Be Presented at American Association for Cancer Research (AACR) Annual Meeting 2021 - Yahoo Finance
finance.yahoo.com - March 11 at 7:03 AM
Theratechnologies Inc. (THTX) CEO Paul Levesque on Q4 2020 Results - Earnings Call Transcript - Seeking AlphaTheratechnologies Inc. (THTX) CEO Paul Levesque on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - February 28 at 7:37 AM
Global Human Immunodeficiency Virus (HIV) Therapeutics Industry to 2029 - Drug Forecast and Market Analysis - ResearchAndMarkets.com - Business WireGlobal Human Immunodeficiency Virus (HIV) Therapeutics Industry to 2029 - Drug Forecast and Market Analysis - ResearchAndMarkets.com - Business Wire
businesswire.com - February 25 at 8:30 AM
Theratechnologies Announces Fourth Quarter and Fiscal Year 2020 Financial Results - GlobeNewswireTheratechnologies Announces Fourth Quarter and Fiscal Year 2020 Financial Results - GlobeNewswire
globenewswire.com - February 25 at 8:30 AM
Theratechnologies to Announce Financial Results for Fourth Quarter and Fiscal Year 2020Theratechnologies to Announce Financial Results for Fourth Quarter and Fiscal Year 2020
finance.yahoo.com - February 11 at 1:15 PM
Theratechnologies Lead Peptide Drug Conjugate TH1902 Receives FDA Fast Track Designation for the Treatment of Sortilin-expressing CancersTheratechnologies' Lead Peptide Drug Conjugate TH1902 Receives FDA Fast Track Designation for the Treatment of Sortilin-expressing Cancers
marketwatch.com - February 5 at 9:57 AM
Theratechnologies’ Lead Peptide Drug Conjugate TH1902 Receives FDA Fast Track Designation for the Treatment of Sortilin-expressing CancersTheratechnologies’ Lead Peptide Drug Conjugate TH1902 Receives FDA Fast Track Designation for the Treatment of Sortilin-expressing Cancers
markets.businessinsider.com - February 4 at 6:34 PM
Theratechnologies’ Lead Peptide Drug Conjugate TH1902 Receives FDA Fast Track Designation for the Treatment of Sortilin-expressing CancersTheratechnologies’ Lead Peptide Drug Conjugate TH1902 Receives FDA Fast Track Designation for the Treatment of Sortilin-expressing Cancers
finance.yahoo.com - February 4 at 8:33 AM
Piramal Pharma Solutions Announces Sterile Fill/Finish Program with Theratechnologies Inc. for TH1902 Peptide-drug ConjugatePiramal Pharma Solutions Announces Sterile Fill/Finish Program with Theratechnologies Inc. for TH1902 Peptide-drug Conjugate
markets.businessinsider.com - January 25 at 7:12 AM
The Theratechnologies (TSE:TH) Share Price Has Gained 104%, So Why Not Pay It Some Attention?The Theratechnologies (TSE:TH) Share Price Has Gained 104%, So Why Not Pay It Some Attention?
finance.yahoo.com - January 22 at 12:35 PM
Theratechnologies to Present at the B. Riley Securities Virtual Oncology Investor ConferenceTheratechnologies to Present at the B. Riley Securities Virtual Oncology Investor Conference
finance.yahoo.com - January 14 at 2:50 PM
Theratechnologies Announces Preliminary Fourth Quarter and Full Fiscal Year 2020 Revenues and Provides Update on R&D ActivitiesTheratechnologies Announces Preliminary Fourth Quarter and Full Fiscal Year 2020 Revenues and Provides Update on R&D Activities
finance.yahoo.com - January 7 at 8:37 AM
Theratechnologies Inc.Theratechnologies Inc.
barrons.com - December 31 at 12:18 AM
Mediaplanet and Chef Gabe Bertaccini Bring Awareness to the HIV/AIDS Epidemic - BenzingaMediaplanet and Chef Gabe Bertaccini Bring Awareness to the HIV/AIDS Epidemic - Benzinga
benzinga.com - December 23 at 7:48 PM
Theratechnologies Announces New Findings for its Lead Investigational Compound TH1902 for the Treatment of Several Additional Cancers - Yahoo FinanceTheratechnologies Announces New Findings for its Lead Investigational Compound TH1902 for the Treatment of Several Additional Cancers - Yahoo Finance
finance.yahoo.com - December 8 at 7:46 AM
Theratechnologies Announces New Findings for its Lead Investigational Compound TH1902 for the Treatment of Several Additional CancersTheratechnologies Announces New Findings for its Lead Investigational Compound TH1902 for the Treatment of Several Additional Cancers
finance.yahoo.com - December 8 at 7:46 AM
Theratechnologies: Canadian Market-Stage Company With Late-Stage PipelineTheratechnologies: Canadian Market-Stage Company With Late-Stage Pipeline
seekingalpha.com - November 29 at 5:44 PM
Theratechnologies Announces Data From Oral Presentation at AASLD Showing How Tesamorelin Can Reduce Fibrosis and NASHTheratechnologies Announces Data From Oral Presentation at AASLD Showing How Tesamorelin Can Reduce Fibrosis and NASH
finance.yahoo.com - November 16 at 1:50 PM
Theratechnologies Announces that Data on the Mechanism of Effect of Tesamorelin in NAFLD will be Presented at The Liver Meeting® 2020Theratechnologies Announces that Data on the Mechanism of Effect of Tesamorelin in NAFLD will be Presented at The Liver Meeting® 2020
finance.yahoo.com - November 6 at 3:09 PM
Theratechnologies CCO resignsTheratechnologies CCO resigns
seekingalpha.com - November 3 at 5:40 PM
Theratechnologies Inc. (TSE:TH) Just Reported Earnings, And Analysts Cut Their Target PriceTheratechnologies Inc. (TSE:TH) Just Reported Earnings, And Analysts Cut Their Target Price
finance.yahoo.com - October 19 at 2:00 PM
Theratechnologies down 4% on Q3 earningsTheratechnologies down 4% on Q3 earnings
seekingalpha.com - October 15 at 2:53 PM
Theratechnologies Announces Financial Results for the Third Quarter of Fiscal 2020Theratechnologies Announces Financial Results for the Third Quarter of Fiscal 2020
markets.businessinsider.com - October 15 at 9:53 AM
Theratechnologies secures new U.S patent for tesamorelin in NASHTheratechnologies secures new U.S patent for tesamorelin in NASH
seekingalpha.com - October 14 at 8:03 AM
Theratechnologies Inc. (TQ8.F)Theratechnologies Inc. (TQ8.F)
in.finance.yahoo.com - October 8 at 10:08 PM
Theratechnologies to Announce Financial Results for Third Quarter 2020Theratechnologies to Announce Financial Results for Third Quarter 2020
markets.businessinsider.com - October 6 at 12:59 AM
Theratechnologies to Present at the H.C. Wainwright 4th Annual NASH Investor Conference on October 5Theratechnologies to Present at the H.C. Wainwright 4th Annual NASH Investor Conference on October 5
markets.businessinsider.com - September 30 at 5:56 PM
Theratechnologies Announces Preliminary Third-Quarter Fiscal 2020 Financial ResultsTheratechnologies Announces Preliminary Third-Quarter Fiscal 2020 Financial Results
benzinga.com - September 21 at 10:18 AM
Theratechnologies guides Q3 revenue below consensusTheratechnologies guides Q3 revenue below consensus
seekingalpha.com - September 21 at 10:18 AM
Theratechnologies Announces Launch of Trogarzo in GermanyTheratechnologies Announces Launch of Trogarzo in Germany
finanznachrichten.de - September 12 at 10:45 PM
Theratechnologies to Develop Tesamorelin for the Treatment of NASH in the General PopulationTheratechnologies to Develop Tesamorelin for the Treatment of NASH in the General Population
finance.yahoo.com - September 10 at 8:39 AM
Theratechnologies to Present at the Canaccord Genuity 40th Annual Growth Conference on August 12, 2020Theratechnologies to Present at the Canaccord Genuity 40th Annual Growth Conference on August 12, 2020
finance.yahoo.com - July 30 at 8:22 AM
Theratechnologies NASH Data And Other News: The Good, Bad And Ugly Of BiopharmaTheratechnologies NASH Data And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - July 26 at 7:28 AM
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.